Scientific Content

Gaucher Mechanism of Disease

Clinical Presentation of Gaucher Patients

Diagnostic Algorithm For Adults of Non-Ashkenazi Jewish Origin

RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation

This video explains WEQAYA's strategy on Nirsevimab Implementation

Guidelines for RSV prevention with Nirsevimab

Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract infections in infants and young children. Nirsevimab is a long-acting monoclonal antibody that provides passive immunization against RSV, offering protection throughout the RSV season with a single dose

An easy guide to use Nirsevimab

Nirsevimab is given for infants entering their first RSV season as a single injection based on infant's weight at the time of dosing

ADCT – Atopic Dermatitis Control Tool

Pre-Ramadan assessment and Risk calculation for people with diabetes who want to fast during Ramadan

The Enlarged Spleen Mystery

Patient With Hepatosplenomegaly and Multiple Splenic lesions/Dr. Ahmed Al Shomer

When Hematological Signs Lead the Diagnosis

A Case of Unexplained Growth Delay with Hematological Manifestation/Dr. Mahmud Al Mutadares

MS pulse - Tracking the hidden drivers of MS progression